PET

PET is a nonprofit organization dedicated to enhancing options for individuals dealing with infertility and genetic disorders.

Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#862548

United Kingdom

#133333

Health/Womens Health

#153

Traffic sources

Monthly visitors

Articles

Fertility in Flux: What Can State-Funded IVF Do for Population Growth? | PET

1 week ago | progress.org.uk | Richard Stephens

A PET event on whether government funded IVF is the answer to population decline.
Event Review: Reproductive Justice in a Changing Climate

1 week ago | progress.org.uk | Joanne Delange |Vanessa Burns

Across the globe, people are experiencing the effects of climate change. But what does this mean in the context of human reproduction and reproductive choice? As part of a series of Cambridge Festival events focusing on 'Reproductive Justice in a Changing Climate', Cambridge Reproduction organised a panel discussion and exhibition that critically dissected this very question.
First baby born following womb transplant in UK

1 week ago | progress.org.uk | Joanne Delange

Amy Isabel has become the first UK baby born following a womb transplant. Her mother, Grace Davidson, received her sister's donated womb (also known as a uterus) in 2023 – the UK's first successful womb transplant (see BioNews 1204 and 1248). The landmark procedure was led jointly by surgeons Professor J Richard Smith and Isabel Quiroga. Together, they lead the charity Womb Transplant UK, which funded the sisters' surgeries.
Polygenic scores could 'turn the tide on prostate cancer'

1 week ago | progress.org.uk | Joanne Delange |Dan Jacobson

An at-home spit test to identify patients at risk of prostate cancer, using a polygenic risk score, has been shown to outperform current testing methods. The initial results of the BARCODE1 study, published in the New England Journal of Medicine, showed that for men with the highest risk of prostate cancer, this new test based on risk-associated genetic variants was more accurate than the standard NHS-applied blood test, which detects the enzyme protein-specific antigen (PSA).
Lab-grown human teeth: the future of regenerative dentistry

1 week ago | progress.org.uk | Joanne Delange

A human tooth has been grown under laboratory conditions by scientists from King's College London. 'This idea of replacing the tooth in a biological way by regrowing it, drew me to London and to King's,' explained the director of regenerative dentistry, Dr Ana Angelova Volponi. 'By growing a tooth in a dish, we are really filling in the gaps of knowledge.'The scientists do, however, explain that the research is a long way from being usable in clinical practice.
Dire wolves have not been brought back from extinction, experts argue

1 week ago | progress.org.uk | Joanne Delange

An article in Time claims that three dire wolf pups have been born. Yet, independent experts argue that they are grey wolves with edits to their DNA to make them resemble the genome of the dire wolf. Ancient DNA was used to identify key segments of code that they could edit into the grey wolf. 'So what... has [been] produced is a grey wolf, but it has some dire wolf-like characteristics, like a larger skull and white fur...
Radio Review: The Body Politic – Surrogacy | PET

2 weeks ago | progress.org.uk | Joanne Delange

Sonia Sodha's podcast series, The Body Politic, explores the intersection of bioethics, bodily autonomy, life, and death. The first episode, Surrogacy, tackled surrogacy in the UK and involved a variety of interest-holders, including intended parents, a surrogate, and two critics of the practice. With this range of speakers presumably ensuring some sort of balance in views, however, I would have liked to have heard from more surrogates, researchers and healthcare professionals.
23andMe: a salutary tale

2 weeks ago | progress.org.uk | Joanne Delange

If you opened the 23andMe website a little while ago, you would have found a special Mother's Day offer of 45 percent off a 23andMe+ premium subscription. This was being promoted during the week in which the company confirmed that it had finally filed a chapter 11 bankruptcy petition (see BioNews 1283). When 23andMe co-founder and resigning CEO, Anne Wojcicki, relayed the news on LinkedIn, she affirmed the intention to continue her fight to take over the company.
What can the exposome tell us about ageing and mortality?

2 weeks ago | progress.org.uk | Joanne Delange

A recent article in Nature Medicine has created quite a stir. The article takes a very broad approach in developing an understanding of ageing and ill-health (see BioNews 1278). The study is huge in every sense.
DNA test reveals babies swapped at birth in Peru

2 weeks ago | progress.org.uk | Joanne Delange

A DNA test to confirm paternity and claim child support led a mother in rural Peru to discover the child she had raised for six years was not biologically hers, or her ex-partner's. The woman, who gave birth at a public hospital in Jaén on Christmas Eve in 2018, was devastated to learn that her son had been mistakenly switched at birth. A second DNA test confirmed the findings, prompting an official investigation into a possible baby swap at birth.